Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Cognitive Dysfunction × Tablets × Clear all

Phase

Status

Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Polycystic Ovary Syndrome 2 Obesity 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Tracheal Diseases 1 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Salivary Gland Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Overweight 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Motor Activity 1 Mesothelioma 1 Meningioma 1 Medulloblastoma 1 Lymphoma 1 Lung Neoplasms 1 Localized Prostate Cancer 1

Interventions

mazdutide 1 lithium sulfate 1 lime 1 fasudil 1 blueberry extract 1 Walking 1 Waiting Lists 1 Transcranial Magnetic Stimulation 1 Transcranial Direct Current Stimulation 1 Therapeutics 1 Tablets 1 Radiotherapy 1 Radiosurgery 1 Patient Reported Outcome Measures 1 Organization and Administration 1 Neuropsychological Tests 1 Modafinil 1 Methods 1 Metformin 1 Mental Status and Dementia Tests 1 Memantine 1 Low-Level Light Therapy 1 Lithium 1 Infliximab 1 Drug Therapy 1 Data Collection 1 Cognitive Behavioral Therapy 1 Chemoradiotherapy 1 Accidental Falls 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡